MedPath

Continuous Glucose Monitoring in New Mothers With Type 1 Diabetes

Completed
Conditions
Breastfeeding
Hypoglycemia
Interventions
Device: Continuous glucose monitoring (CGM)
Registration Number
NCT02898428
Lead Sponsor
Steno Diabetes Center Copenhagen
Brief Summary

With appropriate day-time carbohydrate intake and insulin dose, the 24 hour glucose levels and prevalence of night-time hypoglycaemia are comparable in breastfeeding new mothers and formula feeding new mothers with type 1 diabetes at the second after delivery diabetes control compared with the first after delivery diabetes control at Steno Diabetes Center.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
65
Inclusion Criteria
  • Age between 18 and 45 years.
  • Delivery of a single infant.
  • Proficiency in Danish to read and understand the patient information sheet, questionnaires and to converse with the diabetes caregivers.
Exclusion Criteria
  • A diagnosis with severe mental or psychiatric barriers or a concurrent disease on the decision of the principal investigator

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
New mothersContinuous glucose monitoring (CGM)New mothers with type 1 diabetes
Control groupContinuous glucose monitoring (CGM)Non-pregnant, non-breastfeeding women with type 1 diabetes matched for age and BMI
Primary Outcome Measures
NameTimeMethod
HypoglycemiaNight-time 8 hours
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Steno Diabetes Center Copenhagen

🇩🇰

Gentofte, Denmark

© Copyright 2025. All Rights Reserved by MedPath